200 related articles for article (PubMed ID: 31293418)
1.
Huang Z; Wu Y; Zhou Z; Xia X; Gu X; Cai Q; Shen X; Yang H; Ding H
Front Pharmacol; 2019; 10():670. PubMed ID: 31293418
[No Abstract] [Full Text] [Related]
2. The PK/PD Integration and Resistance of Tilmicosin against
Huang Z; Hu Z; Zheng H; Xia X; Gu X; Shen X; Yang H; Ding H
Pathogens; 2020 Jun; 9(6):. PubMed ID: 32575357
[No Abstract] [Full Text] [Related]
3. The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum.
Zhang N; Gu X; Ye X; Wu X; Zhang B; Zhang L; Shen X; Jiang H; Ding H
Front Microbiol; 2016; 7():653. PubMed ID: 27199972
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Pharmacodynamic integration of tilmicosin against
Zhang N; Zhou M; Yan X; Liu J; Yuan S; Yang H; Ding H; Zhang D; Bai Y
Front Vet Sci; 2022; 9():952599. PubMed ID: 36246335
[No Abstract] [Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic integration and resistance of tiamulin against Mycoplasma hyopneumoniae in an in vitro dynamic model.
Huang Z; Xia X; Mao C; Gu X; Shen X; Yang H; Ding H
Microb Pathog; 2020 Oct; 147():104255. PubMed ID: 32407861
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against
Wang W; Yu J; Ji X; Xia X; Ding H
Microbiol Spectr; 2024 Feb; 12(2):e0367523. PubMed ID: 38112481
[TBL] [Abstract][Full Text] [Related]
7. The PK-PD Relationship and Resistance Development of Danofloxacin against
Zhang N; Wu Y; Huang Z; Yao L; Zhang L; Cai Q; Shen X; Jiang H; Ding H
Front Microbiol; 2017; 8():926. PubMed ID: 28611739
[No Abstract] [Full Text] [Related]
8. Efficacy of Tylosin and Tilmicosin Against Experimental
Garmyn A; Vereecken M; De Gussem K; Depondt W; Haesebrouck F; Martel A
Avian Dis; 2019 Jun; 63(2):359-365. PubMed ID: 31251538
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens.
Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH
Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809
[TBL] [Abstract][Full Text] [Related]
10. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
Jordan FT; Horrocks BK
Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum.
Xiao X; Sun J; Yang T; Fang X; Cheng J; Xiong YQ; Liu YH
Front Vet Sci; 2016; 3():75. PubMed ID: 27656647
[TBL] [Abstract][Full Text] [Related]
12. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA.
Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J
FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901
[TBL] [Abstract][Full Text] [Related]
13. Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry.
Gerchman I; Levisohn S; Mikula I; Manso-Silván L; Lysnyansky I
Vet Res; 2011 Aug; 42(1):90. PubMed ID: 21810258
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/pharmacodynamic profiles of baicalin against Mycoplasma gallisepticum in an in vivo infection model.
Bao J; Wu Z; Ishfaq M; Wang J; Miao Y; Niu D; Li R; Li J; Chen C
Poult Sci; 2021 Nov; 100(11):101437. PubMed ID: 34547622
[TBL] [Abstract][Full Text] [Related]
15. Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.
Zhang N; Ye X; Wu Y; Huang Z; Gu X; Cai Q; Shen X; Jiang H; Ding H
PLoS One; 2017; 12(1):e0169134. PubMed ID: 28052123
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against
Zhang H; Mao C; Li J; Huang Z; Gu X; Shen X; Ding H
Front Pharmacol; 2019; 10():1088. PubMed ID: 31620004
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacokinetics of tilmicosin in plasma and lung tissue in healthy chickens and chickens experimentally infected with Mycoplasma gallisepticum.
Zhang N; Liu Z; Wei Y; Zhang C; Mao C; Cai Q; Shen X; Ding H
J Vet Pharmacol Ther; 2020 Jul; 43(4):347-354. PubMed ID: 32133660
[TBL] [Abstract][Full Text] [Related]
18. Mutations in 23S rRNA gene associated with decreased susceptibility to tiamulin and valnemulin in Mycoplasma gallisepticum.
Li BB; Shen JZ; Cao XY; Wang Y; Dai L; Huang SY; Wu CM
FEMS Microbiol Lett; 2010 Jul; 308(2):144-9. PubMed ID: 20487023
[TBL] [Abstract][Full Text] [Related]
19. Emergence and Mechanism of Resistance of Tulathromycin Against
Xia X; Yang L; Ling Y; Yu J; Ding H
Front Vet Sci; 2022; 9():801800. PubMed ID: 35224081
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.
Sato T; Higuchi H; Yokota SI; Tamura Y
Microbiol Immunol; 2017 Jun; 61(6):215-224. PubMed ID: 28504455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
